Author | Djordje Atanackovic, MD

Articles

Current Strategies for the Immunotherapy of Multiple Myeloma

January 15, 2017

ByTim Luetkens, MD|Sara Yousef, PhD|Sabarinath Venniyil Radhakrishnan, MD|Djordje Atanackovic, MD

Here we outline the most promising novel cellular immune strategies for patients with multiple myeloma. In addition, we highlight combinatorial approaches that, it is hoped, will further optimize cellular immunotherapies for myeloma and lead to deep and durable responses and, possibly, even cures.